Post-Doctoral Scientist - Analytical - Network TSMS at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalIndustries

Requirements

PhD (Post-Doctoral position)
Expertise in scientific principles for manufacturing intermediates and bulk drug substances, including chemistry-equipment interactions
Understanding of chemistry and stability of synthetic and biomolecules and associated analytical tools
Ability to develop laboratory-scale models and methods for key process steps in reactions and purification of peptides and biomolecules
Knowledge of scale-up requirements and ability to partner with manufacturing plants for scale-up and investigative work
Familiarity with pharmaceutical industry, Good Manufacturing Practices (GMP), and regulatory requirements

Responsibilities

Ensuring reliability of manufacturing systems
Searching for and implementing innovative improvements
Driving technical projects
Maintaining processes in compliance with US and global regulations
Designing and developing drug manufacturing and delivery systems
Designing and executing experiments to advance manufacturing knowledge, process optimization, and production technical transfer
Contributing to cross-functional teams
Understanding scientific principles for manufacturing intermediates and bulk drug substances
Designing, conducting, and analyzing experiments to deepen process understanding and optimize process steps and reactions
Providing technical support for other process development areas as needed
Documenting all work appropriately
Mentoring lab associates to enhance their technical skills

Skills

manufacturing systems

process improvements

technical projects

regulatory compliance

drug manufacturing

drug delivery systems

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free